FDA panel considers loosening regulations on certain unapproved peptides
The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.
📌 Source
This summary is auto-compiled from XML. Visit the original article for the full text.
Read original article →News AI World — Mobile app
Get these headlines in 45 languages, with instant translation, on your phone. Drop your Gmail for early access.